Key result
Globally, the age-standardized mortality rate attributable to high systolic blood pressure decreased from 1990 to 2019, while the age-standardized rate of years lived with disability remained unchanged.
Why the study?
High systolic blood pressure remains the leading global risk factor for mortality, but limited data have revealed all-cause and cause-specific burdens attributable to it at global and regional levels.
Observational
Despite a global decline in mortality rates attributable to high systolic blood pressure from 1990 to 2019, the burden of disability has remained stable, with significant disparities persisting across sociodemographic regions.
Answers are grounded in this paper and cite their sources.
HSBP-related disability burden remains stable despite mortality declines; leaves open targeted strategies to address persistent morbidity and regional disparities.
Objective: High systolic blood pressure (HSBP) remains the leading risk factor for mortality worldwide; however, limited data have revealed all-cause and cause-specific burdens attributed to HSBP at global and regional levels. This study aimed to estimate the global burden and priority diseases attributable to HSBP by region, sex, and age. Methods: Based on data and evaluation methods from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019, we estimated trends of age-standardized mortality rate (ASMR), the age-standardized rate of disability-adjusted life years (ASDRs), and the age-standardized rate of years lived with disability (ASYRs) attributable to HSBP during 1990-2019. Further, we analyzed cause-specific burdens attributable to HSBP by sex, age, year, and region. Results: Globally, a significant downtrend was found in the ASMR attributed to HSBP while ASYRs did not change substantially during 1990-2019. The majority of HSBP burden has shifted from high-middle sociodemographic index (SDI) regions to lower SDI regions. All-cause and most cause-specific burdens related to HSBP were improved in high SDI regions but the downtrends have stagnated in recent years. Although many cause-specific deaths associated with HSBP declined, chronic kidney disease (CKD) and endocarditis associated deaths were aggravated globally and ischemic heart disease (IHD), atrial fibrillation and flutter, aortic aneurysm (AA), and peripheral artery disease (PAD) associated deaths were on the rise in low/low-middle/middle SDI regions. Additionally, males had higher disease burdens than females. Middle-aged people with CVDs composed the major subgroup affected by HSBP while older people had the highest ASMRs associated with HSBP. Conclusions: This study revealed the global burden and priority diseases attributable to HSBP with wide variation by region, sex, and age, calling for effective and targeted strategies to reduce the prevalence and mortality of HSBP, especially in low/low-middle/middle SDI regions.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) conducted an observational in High systolic blood pressure. High systolic blood pressure vs. Theoretical minimum risk exposure level (110-115 mm Hg) was evaluated on Age-standardized mortality rate (ASMR) attributable to high systolic blood pressure (EAPC -1.32, 95% CI -1.36 to -1.27). Globally, the age-standardized mortality rate attributable to high systolic blood pressure decreased from 1990 to 2019, while the age-standardized rate of years lived with disability remained unchanged.
Synapse has enriched 10 related papers. Consider them for comparative context: